Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: E_K_S who wrote (78005)	8/31/2025 4:48:38 PM
From: Sean Collett	Read Replies (1) \| Respond to of 78505

I don't believe anything you shared actually challenges the point I made to Elroy though. There are secondary issues that AI won't solve via MRI for all. AI has been in the medial field for YEARS especially in imaging. Has it helped? Of course, I never said it didn't. It is not magic though and regardless secondary tests are needed. Taking patient records and scanning and then giving a doctor a read-out of likely illness is different than what was initially proposed. In any scan 2-3 things will be found and you will need to run further tests to confirm them. This puts the patient through possible unnecessary and costly tests and mental strain. It is one of the standard reasons this isn't done today because often the results are benign. AI scanning the image won't change that because additional layers are required for verification as well as natural limits of the MRI. Now if you're playing the data game for Oracle then that's different. I recall reading an article from 2020 there was some stat that medical data was to double every 73 days. The challenge I see is AI has been in this space for years and isn't new even if most of us are just now getting access to these tools ourselves. More data helps but there are challenges with "more data" too. Also any idea what drives this in your reply? "However, recent reports from industry analysts have noted some challenges, including customer dissatisfaction and a decline in market share for Oracle Health in the acute care hospital segment." AI has been in the medical space for decades and while tools will improve and patient care will with it, I think exponential growth isn't what many expect. I remain skeptical but happy to be proven wrong in time. Happy investing, Sean